Enhancer retargeting of <i>CDX2</i> and <i>UBTF::ATXN7L3</i> define a subtype of high-risk B-progenitor acute lymphoblastic leukemia
Shunsuke Kimura(St. Jude Children's Research Hospital), Charles G. Mullighan(St. Jude Children's Research Hospital), Zhaohui Gu(City of Hope), Breon Schmidt(The University of Melbourne), Selina M. Luger(University of Pennsylvania), Qingsong Gao(St. Jude Children's Research Hospital), Jacqueline Rehn(South Australian Health and Medical Research Institute), Ching‐Hon Pui(St. Jude Children's Research Hospital), Claudia Haferlach(Munich Leukemia Laboratory (Germany)), Stephen P. Hunger(Children's Hospital of Philadelphia), James Breen(South Australian Health and Medical Research Institute), Deborah L. White(ANZCHOG), Sean M. Grimmond(The University of Queensland), Ibrahim Aldoss(City of Hope), Manja Meggendorfer(Université Paris-Sud), Torsten Haferlach(Martin Luther Christian University), Kathryn G. Roberts(St. Jude Children's Research Hospital), Samuel W. Brady(St. Jude Children's Research Hospital), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Elias Jabbour(The University of Texas MD Anderson Cancer Center), Piers Blombery(The Royal Melbourne Hospital), Wencke Walter(Munich Leukemia Laboratory (Germany)), Yaqi Zhao(St. Jude Children's Research Hospital), Ilaria Iacobucci(St. Jude Children's Research Hospital), Lindsey E. Montefiori(St. Jude Children's Research Hospital), Alicia Oshlack(Walter and Eliza Hall Institute of Medical Research), Georgina L. Ryland(The University of Melbourne), Jacob M. Rowe(Shaare Zedek Medical Center), Elisabeth Paietta(Montefiore Medical Center), Mark R. Litzow(Mayo Clinic in Arizona), Paul G. Ekert(Royal Children's Hospital), Alexander Laird(Pfizer (United States)), Jinghui Zhang(St. Jude Children's Research Hospital), David T Yeung(Royal Adelaide Hospital), Paul E. Mead(St. Jude Children's Research Hospital), Wendy Stock(University of Chicago)
Cited by 50
Related Papers
The Sequence of the Human Genome
|Science|2001|13.7k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Whole genomes redefine the mutational landscape of pancreatic cancer
|Nature|2015|2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k